REGEN BIOPHARMA, INC.

RGBP ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $1.2M

Liabilities Breakdown FY2021

Total Liabilities: $14.7M